FDA Floats Broader Pathway For Nicotine Replacement Therapies
This article was originally published in The Tan Sheet
Executive Summary
FDA’s report to Congress on tobacco abstinence therapy points toward a “comprehensive strategy” for tobacco and nicotine product regulation, incorporating the work of the drug, device and tobacco centers. Some smoking cessation experts say changes are overdue.